HSPA1A and cancer: Therefore, although avoiding elevated extracellular Hsp70 may be a favorable approach in anticancer therapies, surface Hsp70 positivity of survival cancer cells stressed by therapy may account for a therapeutic advantage if an enhanced immune response against the resistant populations is achieved.